Primary Site >> Liver Cancer

Gene >> ASS1

Journal: Surgery. 2010 Aug;148(2):310-8.
Title: Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthetase-1.
Author: Glazer, Evan S|Kaluarachchi, Warna D|Massey, Katheryn L|Zhu, Cihui|Curley, Steven A
PMID: 20466402
Journal: Cancer Res Treat. 2013 Dec;45(4):251-62.
Title: Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges.
Author: Phillips, Melissa M|Sheaff, Michael T|Szlosarek, Peter W
PMID: 24453997
Journal: J Proteome Res. 2014 Nov 7;13(11):4833-46.
Title: Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients.
Author: Tan, Gek San|Lim, Kiat Hon|Tan, Hwee Tong|Khoo, May Lee|Tan, Sze Huey|Toh, Han Chong|Ching Ming Chung, Maxey
PMID: 24946162
Journal: BMC Cancer. 2014 Sep 20;14:686.
Title: Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-kappaB signaling.
Author: Liu, Jiangbo|Ma, Jiguang|Wu, Zheng|Li, Wei|Zhang, Dong|Han, Liang|Wang, Fengfei|Reindl, Katie M|Wu, Erxi|Ma, Qingyong
PMID: 25240403